[Prognostic aspects of pediatric urinary tract infections].
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009582:Nitrofurantoin / Q000627:therapeutic use*; D011379:Prognosis; D011704:Pyelonephritis / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D002701:Chloramphenicol; D009582:Nitrofurantoin
Prognostische Aspekte kindlicher Harnwegsinfektionen.